Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
The Journal of biological chemistry
2025
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/40158855/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- PEX1 remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome. Sheedy, Connor J Chowdhury, Soham P Ali, Bashir A Miyamoto, Julia Pang, Eric Z Bacal, Julien Tavasoli, Katherine U Richardson, Chris D Gardner, Brooke M Peroxisomes Humans Proteasome Endopeptidase Complex Proteolysis ATPases Associated with Diverse Cellular Activities Membrane Proteins Saccharomyces cerevisiae Proteins Peroxins Saccharomyces cerevisiae Mutation, Missense HEK293 Cells Peroxisome-Targeting Signal 1 Receptor The PEX1/PEX6 AAA-ATPase is required for the biogenesis and maintenance of peroxisomes. Mutations in HsPEX1 and HsPEX6 disrupt peroxisomal matrix protein import and are the leading cause of peroxisome biogenesis disorders. The most common disease-causing mutation in PEX1 is the HsPEX1 allele, which results in a reduction of peroxisomal protein import. Here, we demonstrate that the homologous yeast mutant, ScPex1, reduces the stability of Pex1's active D2 ATPase domain and impairs assembly with Pex6 in vitro, but can still form an active AAA-ATPase motor. In vivo, ScPex1 exhibits only a slight defect in peroxisome import. We generated model human HsPEX1 cell lines and show that PEX1 is rapidly degraded by the proteasome, but that induced overexpression of PEX1 can restore peroxisome import. Additionally, we found that the G843D mutation reduces PEX1's affinity for PEX6, and that impaired assembly is sufficient to induce degradation of PEX1. Lastly, we found that fusing a deubiquitinase to PEX1 significantly hinders its degradation in mammalian cells. Altogether, our findings suggest a novel regulatory mechanism for PEX1/PEX6 hexamer assembly and highlight the potential of protein stabilization as a therapeutic strategy for peroxisome biogenesis disorders arising from the G843D mutation and other PEX1 hypomorphs.